To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis
Clinical trial NCT02057250 · COMPLETED
Trial details
- NCT number
- NCT02057250
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.